[MDGL] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
09-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -0.19%
YoY- 40.47%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -57,963 -21,429 -8,512 -8,363 -14,049 -17,628 -19,966 19.41%
Tax 0 0 0 100 -11,991 0 0 -
NP -57,963 -21,429 -8,512 -8,363 -14,049 -17,628 -19,966 19.41%
Tax Rate - - - - - - - -
Total Cost 57,963 21,429 8,512 8,363 14,049 17,628 19,966 19.41%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -3.75 -1.39 -0.56 -0.68 -1.59 -102.46 -6.61 -9.00%
EPS Diluted -3.75 -1.39 -0.56 -0.68 -1.59 -102.46 -6.61 -9.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.